AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 178 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $346,000 | +19.3% | 6,700 | 0.0% | 0.00% | – |
| Q4 2020 | $290,000 | +23.4% | 6,700 | 0.0% | 0.00% | – |
| Q3 2020 | $235,000 | -36.3% | 6,700 | -2.9% | 0.00% | – |
| Q2 2020 | $369,000 | +48.8% | 6,900 | -1.4% | 0.00% | – |
| Q1 2020 | $248,000 | +12.7% | 7,000 | +52.2% | 0.00% | – |
| Q4 2019 | $220,000 | +47.7% | 4,600 | 0.0% | 0.00% | – |
| Q3 2019 | $149,000 | -97.2% | 4,600 | -95.7% | 0.00% | -100.0% |
| Q2 2019 | $5,344,000 | -44.6% | 107,134 | -25.1% | 0.00% | -71.4% |
| Q1 2019 | $9,648,000 | +4899.0% | 143,050 | +3306.0% | 0.01% | – |
| Q4 2018 | $193,000 | -73.4% | 4,200 | -55.3% | 0.00% | -100.0% |
| Q3 2018 | $725,000 | – | 9,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |